Researchers used adenine base editing in mice to correct a mutation that causes Dravet syndrome. The edit reduced seizures, ...

What was achieved: Researchers corrected SCN1A mutations in mice using prime or base editing, reducing seizures and improving survival. Why it matters: These are the first demonstrations of directly ...

Ocugen, Inc. (Ocugen or the Company) (NASDAQ: OCGN), a pioneering biotechnology leader in gene therapies for blindness diseases, today announced the closing of $130.0 million aggregate principal ...

FDA approved five new gene- and cell-based therapies for patients with rare genetic diseases and hematologic cancers, including therapies for spinal muscular atrophy, Wiskott-Aldrich syndrome, ...

A Purdue University–affiliated startup working to reshape how staple crops are bred has secured new federal funding aimed at ...

High-tech assisted reproduction is a growing sector for farmers but critics say they jeopardize animal welfare ...

Cibus' herbicide partner for its Rice HT traits, Albaugh, has made substantial positive progress for the herbicide registration process in the U.S. for Rice, however, they are behind initial timeline ...

Image via Metro-Goldwyn-Mayer Hard science fiction is a unique subgenre that was originally coined by science fiction author ...

Best Agriculture Stocks to Buy in 2020 Bayer Aktiengesellschaft (ETR:BAYN) executives said the company's Crop Science ...

Reported positive three-year data from the Phase 1 AQUAx study of AAV2-hAQP1 for the treatment of grade 2/3 late radiation-induced xerostomia Entered into an asset purchase agreement with Johnson & ...

Corteva, Inc. (CTVA) 21st Annual Global Farm to Market Conference May 14, 2026 11:00 AM EDTCompany ParticipantsCharles Magro - CEO & ...